News
ASAM Announces 2026 Class of Distinguished Fellows
Rockville, MD (Jan. 21, 2026) - The Âé¶¹´«Ã½ÔÚÏß (ASAM) today announced a new class of Distinguished Fellows of ASAM (DFASAM).
The Distinguished Fellows designation was developed in 1996 to honor ASAM physician members for their significant contributions to both the Society and the broader field of addiction medicine. Recipients are recognized as ASAM’s most active volunteers, advocates, and leaders; their service has proven integral to advancing ASAM’s mission to be the physician-led professional community for those who prevent, treat, and promote remission and recovery from the disease of addiction.
The 2026 DFASAM recipients are as follows:
Sarah W. Book, MD, DFASAM
David Fiellin, MD, DFASAM
Hiroko Furo, MD, DFASAM
Sandra Gomez Luna, MD, DFASAM
Noel Ilogu, MD, MRCP, DFASAM
Robert Levy, MD, DFASAM
Moxie J. Loeffler, DO, MPH, DFASAM
Carla Marienfeld, MD, DFASAM
Smita Prasad, MD, MBA, MPH, CMRO, DFASAM
Kristin Van Zant, MD, DFAPA, DFASAM
Elise Wessol, DO, DFASAM
The 2026 class will be recognized at the held in San Diego, CA, April 23-26, 2026.
This designation is granted yearly to select physician members who meet qualifying criteria, such as serving on the Board of Directors, chairing an ASAM committee or task force, authoring content three or more times in an ASAM national publication, or completing a term as an officer to an active Chapter of ASAM. Distinguished Fellows must also demonstrate contributions to their community in addiction or substance-use related services. Qualifying activities include teaching contributions in a graduate-level program setting, exhibiting a strong commitment to volunteerism by participating in non-compensated activities, such as volunteer work at community health agencies, among other criteria. More information about eligibility can be found here.
# # #
About the Âé¶¹´«Ã½ÔÚÏß
The Âé¶¹´«Ã½ÔÚÏß (ASAM), founded in 1954, is a professional medical society representing over 8,000 physicians, clinicians, and associated professionals in the field of addiction medicine. Âé¶¹´«Ã½ÔÚÏß is dedicated to increasing access and improving the quality of addiction treatment, educating physicians and the public, supporting research and prevention, and promoting the appropriate role of physicians in the care of patients with addiction. For more information, visit www.ASAM.org.
Media Contact
Sarah Shelson
301-547-4110
sshelson@ASAM.org